Centagen
        
        
    
            
                    Company developing multi-path therapeutics for age-related disorders via activating adult stem cells
                             
     
    
        | | Centagen develops protocols and techniques for expanding AS cells in the patient's body or for expanding a patient's AS cells some million fold in special stem cell incubators while preventing cell aging or functional loss. In developing incubator stem cell techniques, Centagen will be able to remove AS cells from a patient in a doctor's office visit, isolate and expand their own AS cells in the cell incubator for several weeks without aging or changing them, and then return the expanded AS cell population to the patient. We are also developing the technology to return AS cells to a more youthful state. The source of AS cells can be from whole blood, bone marrow, belly fat, facial or body skin, nasal passage, hair follicle, or dental tissue. Returning the greatly expanded adult stem cell population back to the patient has the potential to regenerating many tissues and organs. Many off-shore clinics are already providing patients with some AS services and Centagen could greatly help these clinics by expanding their patients' AS cells to greatly enhance AS therapeutic efficacy. Our proprietary technology is furthest along using AS cells from blood, which can form into many end tissues in blood vessels, bone, cartilage, immune system, retina, kidney, and heart. | 
 | 
     
        Visit website: http://centagen.com/
        Details last updated 23-Apr-2020
        
        Centagen News
        
            
                
                
                    
                        
                        Institute for Ethics and Emerging Technologies (IEET) - 14-May-2013
                     
                 
             
         
        
            People at Centagen
        
                    
            
                
                    
                    
                        
                        
                                                                                
                        
                            President and CSO of Centagen.